Global Market Study on Double Chamber Prefilled Syringes: Focus on Sterility, Safety, and Accuracy Driving Adoption


Double Chamber Prefilled Syringes  Market
  • Published On : Jun-2019 |
  • Pages : 275 Pages |
  • Format : PPT PDF Excel Word

Convenience – The Real USP of Double Chamber Prefilled Syringes

Innovation in the pharmaceutical industry moves to another level as user-friendliness becomes the real USP of biotech products. Development of double chamber prefilled syringes is one such transformation brought in by manufacturers to mitigate the risks associated with the reconstitution and erroneous dosage of drugs.

In the parenteral drug delivery systems, where standard syringes remain optimally effective for nearly 12 hours, manufacturers are pushing the bars and developing double chamber prefilled syringes with the sterility of nearly 2-3 years and beyond. With an utmost focus on safety, double chamber prefilled syringes allowing the drug to inject to the required depth, without any supervision are made widely available to varied segments via streamlined distribution channels.

Besides hospitals and clinics, the home-care segment is emerging, and will continue to remain at the forefront of the demand for double chamber prefilled syringes, as end users develop a proclivity for self-care. The innovation brought in by manufacturers are highly resonating with the end users, thereby boding profitable indicators for the double chamber prefilled syringes in the future. Persistence Market Research (PMR), in its recent study, records the historic, current, and futuristic trends that are likely to influence the double chamber prefilled syringes market and offers actionable intelligence to the stakeholders.

double chamber prefilled syringes market strategy

How Will the Double Chamber Prefilled Syringes Market Evolve?

As the administration of drugs and time-consuming processes such as cleaning, siliconization, and sterilization became a long-standing challenge in the nursing centers, the quest for ready-to-use syringes engendered the evolution of double chamber prefilled syringes. The injection of the drug with a little ‘twist and push’ started gaining double chamber prefilled syringes the desired momentum, in exchange for its efficiency; following which, the sales of double chamber prefilled syringes closed in on US$ 1,400 Mn in 2018.

Rigorous research and development efforts, as put by manufacturers, have enabled double chamber prefilled syringes to outperform its traditional rival -vials, with an ability to control wastage of drugs and offer greater shelf life. With the stringent quality filters set by governments of developed countries, in the form of regulatory norms, manufacturers operate under the pressure and develop safe double chamber prefilled syringes, which has been propelling the shift of end users from hospital to home-based care. Considering the crucial parameters, trends, and challenges, PMR’s study estimates that the double chamber prefilled syringes market will record nearly 9% CAGR over the course of the forecast period 2019-2029.

double chamber prefilled syringes market north america

Glass to Maintain Gold Standard for the Development of Double Chamber Prefilled Syringes

Since manufacturers seek a non-reactive and heat and chemical resistant material for the manufacturing of double chamber prefilled syringes, glass maintains the gold standard. However, the advancement towards plastic is gaining eminence, as robustness wins over breakability, during the transportation of the double chamber prefilled syringes. By 2029, plastic is likely to remain the high-growth material segment and will account for 2/5th of the total market share with firsthand concerns of plunger failures prevailing in the landscape.

As self-administration highly dictates the sales of double chamber prefilled syringes, manufacturers expend their efforts in making their products available to their clientele. Being a primary distribution channel, hospital pharmacy accounts for the sales of nearly half of the double chamber prefilled syringes. However, retail and online pharmacies, in turn, occupy a significant share, with the latter surpassing the former and turning into a high-growth distribution channel.

As trends of customization make inroads, the double chamber prefilled syringes industry is poised to offer personalized drug delivery systems to penetrate deeper into the end users’ space. Though the very characteristic of the design of double chamber prefilled syringes is capable of reducing drug wastage, its high price tag causes a reluctance among end-users towards its adoption. Add to that the complex manufacturing process, and the delivery drug systems turn more expensive. Henceforth, end users still maintain a strong grip on the vials, on account of its cost-efficiency, which remains an unsettled challenge for double chamber prefilled syringes manufacturers.

Double Chamber Prefilled Syringes Market – Winning Imperatives

Bring ‘Sterility, Safety, and Accuracy’ to the Fore

A majority of landscape of double chamber prefilled syringes market revolves around product innovation. The edge of a double chamber prefilled syringe becomes a leap for the other. With numerous competitors at play in the market, effectiveness of product becomes a key to unlock the end-users’ application area through research and development activities. For instance, Nipro Corporation developed a double chamber prefilled syringe enriched with a novel safety mechanism called – Needle Protector- to control puncture accidents.

Since the price tag of the double chamber prefilled syringes also play a pivotal role in sales closure, manufacturers are required to develop novel products with competitive prices. This will help them widen their sales window in developing countries such as India, Mexico, and China, where players can expand their clientele base by offering cost-effective products.

Target Countries with High Hemophilia and Diabetes Incidences

Since modern end users tend to seek convenience, streamlining of distribution channels has become a need. With the perpetually growing popularity of eCommerce channels, manufacturers are leveraging both brick and mortar pharmacies as well as online pharmacies to grow in terms of revenue and end users.

Primarily, the market players partner with regional distributors to gain deeper penetration of their products. As patients suffering from Hemophilia, followed by Diabetes remain at the forefront of adoption of double chamber prefilled syringes in the U.S., Germany, Japan, U.K. and China, the formation of a robust distribution network in these regions can help gain lucrative sales opportunities.

Gauging the Competition Intensity of the Fragmented Double Chamber Prefilled Syringes Market

The double chamber prefilled syringes market remain highly fragmented with numerous players catering to individual countries and only a handful of companies having an international footprint. Expansion by acquisition persists as the key strategy of frontrunners, who account for over 52% of the total market share. For instance, Otsuka America Pharmaceutical Inc., focuses the low and mid-income level countries of Asia Pacific to generate its business. Additionally, they invest in patenting their products and getting it commercially approved. For example, Otsuka Pharmaceutical Co., Ltd. and H.Lundbeck A/S averred that the FDA has approved their product -ABILEY MAINTEA®, for the monotherapy treatment of bipolar I disorder in adults. In contrast, the regional players operate at a different level with distinguished strategies.

The regional players –

  • Pfizer Inc.,
  • Credence MedSystems, Inc.,
  • AstraZeneca Plc.,
  • Maeda Industry Co., Ltd-

hold a market share of nearly 30%. Key strategy of the regional players is to focus on the expansion of their manufacturing facility. For instance, in March 2017, AstraZeneca PLC inaugurated a novel facility in Chennai, with a view to tapping the potential of the Indian market.



Double Chamber Prefilled Syringes Market Segmentation

Analysts’ Take on the Double Chamber Prefilled Syringes Market

The author(s) of the report maintains an optimistic perspective on the future growth of the double chamber prefilled syringes market. Manufacturers who expend their efforts in the development of cost-effective double chamber prefilled syringes will gain pace and will be able to overcome any potential threats by vials. Geographies with a large pool of patients suffering from hemophilia and diabetes will foster the leaps of market players. Since the end-users include but are not confined to hospitals and clinics, online retail stores will play a significant role in driving sales from the patients opting home care. If the manufacturing complexity is reduced, the cost of the double chamber prefilled syringes can be brought down significantly and manufacturers can offset the risk arising from alternatives.

Read More

Convenience of Using Double Chamber Prefilled Syringes Creating Significant Opportunities

The global double chamber prefilled syringes market is valued at approximately US$ 1.5 Bn, and it is expected to grow at a CAGR of 9% during the assessment period. The double chamber prefilled syringes market is primarily led by the sales of (<1.0 mL) segment. Pharmaceutical companies are achieving success by offering double chamber prefilled syringes that contain lyophilized as well as liquid formulations. For caregivers, such syringes not only simplify the process, but also help save a lot of time. Medical products that can save valuable time in the treatment and care of patients have often been well-received. Moreover, double chamber prefilled syringes have enhanced comfort for end users, which include caregivers and patients.

The characteristics of double chamber prefilled syringes allow reconstitution directly inside the system. Double chamber prefilled syringes facilitate next-generation drug delivery technology and are more patient-centric as compared to traditional modes. The design of prefilled syringes enables drug makers to expand their lyophilized and biological drug capabilities. Thus, the foray of key market players into the lyophilized double chamber prefilled syringes market, coupled with the high adoption of double chamber prefilled syringes due to the high convenience associated with their usage, are among the key factors that are projected to propel the revenue growth of the double chamber prefilled syringes market.

Increasing Requirement of Highly Efficient Parenteral Drug Delivery Modes to offer Growth Opportunities

It has been witnessed over a period of time that a considerable percentage of all FDA approvals for parenteral drugs were given for lyophilized products. This is subsequently creating a greater requirement for more efficient parenteral drug delivery systems, thereby boosting the global demand for dual and multichamber prefilled syringes. Drug delivery systems can play an important role in influencing the efficacy of constituted drugs. Traditional modes are sometimes likely to impact the overall drug delivery process due to their limitations, whereas double chamber prefilled syringe technology ensures highly efficient drug use through precise product constitution. Double chamber prefilled syringes are specifically designed for highly sensitive drugs, such as probiotics, proteins, etc., to maintain their desired shelf life. The actual active ingredient of the drug is lyophilized in one of the two chambers, while the other chamber of the prefilled syringe contains a solvent that mixes with the active substance immediately before the application. Thus, the increasing requirement of highly efficient parenteral drug delivery modes is expected to promote the adoption and sales of double chamber prefilled syringes, which is estimated to enhance the revenue growth of the global double chamber prefilled syringes market.

Increased Focus on User Safety boosting the Revenue Generation

Manufacturers are actively focusing on improving the product efficiency of double chamber prefilled syringes and their safety of use. To adhere to user safety laws, manufacturers are incorporating safety features into their products. Although the number of marketed double chamber prefilled syringes with integrated safety features is currently low, more manufacturers are likely to get inclined toward the trend in the near future. Several manufacturers of double chamber prefilled syringes are also entering into joint product development programs. Partnerships and collaborations are expected to increase further in the future as such strategic alliances enable companies offering double chamber prefilled syringes to exchange their expertise and utilize their synergies in a more efficient manner. Research and development projects in pharmaceutical packaging require a significant amount of investments and time. Thus, the introduction of new technology in the double chamber prefilled syringes market enables key manufacturers to strengthen their business footprint by introducing innovative and upgraded user-safety features in double chamber prefilled syringes, thereby driving the global revenue in the double chamber prefilled syringes market.

For more such actionable insights on the potential of the double chamber prefilled syringes market, request a free sample copy.

Competitive Landscape

  • The competition section of the double chamber prefilled syringes market features the profiles of the key players operating in the market based on their shares, differential strategies, product offerings, marketing approach, and company dashboard. Some of the key players operating in the double chamber prefilled syringes market include Pfizer Inc.
    • Biosciences, Inc.
    • Ypsomed AG,
    • Otsuka America Pharmaceutical, Inc.
    • Credence MedSystems, Inc.
    • Vetter Pharma International GmbH
    • MAEDA INDUSTRY Co., Ltd.
    • AstraZeneca plc
    • AbbVie Inc.
    • Nipro Corporation
    • SCHOTT AG.

Request information on the double chamber prefilled syringes market landscape.

Definition

The double chamber prefilled syringes market report involves a study of double chamber prefilled syringes, which are categorized on the basis of syringe volume. A dual chamber prefilled syringe is fundamentally used for the packaging of lyophilized small doze parenteral medicine. It consists of two chambers, of which one contains the powder form of the pharmaceutical substance to be injected, while the other chamber contains the solvent in which the lyophilized agent is to be dissolved. The development of such syringes is a result of the rapid proliferation of biological drugs that require lyophilization.About the Report

PMR has conducted a research study on the double chamber prefilled syringes market for the forecast period 2019 to 2029. The double chamber prefilled syringes market report offers a comprehensive evaluation of the business opportunities available in the double chamber prefilled syringes market, along with insights on the consumption of double chamber prefilled syringes, incidence of diseases such as diabetes, schizophrenia, & endometriosis, and the competitive landscape of the double chamber prefilled syringes market. The report elaborates on the macroeconomic factors that are influencing the dynamics of the double chamber prefilled syringes market along with its futuristic potential.

Segmentation

The report offers a comprehensive taxonomy of the double chamber prefilled syringes market based on the product type, material type, application, indication, distribution channel, and region. Distinct double chamber prefilled syringes products in the market include <1.0 mL, 1.0 – 2.5 mL, 2.5 – 5.0 mL, and >5 mL double chamber prefilled syringes. Double chamber prefilled syringes registers substantial revenue in the liquid/lyophilisate application segment. The double chamber prefilled syringes market has been comprehensively analyzed across the regions of North America, Latin America, Europe, South Asia, East Asia, Oceania, and MEA.

Additional Questions Answered

Some of the additional questions addressed in the double chamber prefilled syringes market report are:

  • What is the revenue potential of the double chamber prefilled syringes market across the regions of North America and Europe?
  • Who are the key competitors in the double chamber prefilled syringes market and what are their portfolios?
  • What are the major challenges affecting the growth of the double chamber prefilled syringes market?
  • How is the reimbursement landscape in the double chamber prefilled syringes market impacting the growth of the market?

For answers to all the possible questions required for gauging the performance of the Double Chamber Prefilled Syringes market, get in touch with our expert analyst.

Research Methodology

The double chamber prefilled syringes market has been estimated based on the consumption and supply-demand approach. The market was first calculated based on the consumption of double chamber prefilled syringes and the sales of these syringes in different regions/countries, especially in the top 20 countries globally, for six  disease indications. Other qualitative factors analyzed during the value estimation of the double chamber prefilled syringes market include the level of awareness regarding the availability of products. This information is further validated with thorough primary research, which includes surveys, interviews, and in-person interactions, along with the viewpoints of seasoned analysts, and secondary research that comprises authentic trade journals, resourceful databases, and verified paid sources. The research study on the double chamber prefilled syringes market also includes the top trends and macro as well as microeconomic factors shaping the double chamber prefilled syringes market. With this approach, the report on the double chamber prefilled syringes market estimates the industry attractiveness of every major segment of the double chamber prefilled syringes market over the forecast period.  

Double Chamber Prefilled Syringes Market – Introduction

Persistence Market Research (PMR) recently published a report on double chamber prefilled syringes market for the forecast period 2019-2029. The business asset offers a detailed assessment of the crucial parameters driving the growth of the double chamber prefilled syringes market. Post a comprehensive analysis of the historic, current, as well as the futuristic trends shaping the growth of the double chamber prefilled syringes market, statistics and data have been presented in the report.

The report begins with a detailed executive summary, which presents a gist of key findings of the double chamber prefilled syringes market, backed with reliable data. The double chamber prefilled syringes market has been estimated in terms of value (US$ Mn) over the course of the forecast period.

The comprehensive business asset offers a detailed outlook on the significant developments and product innovations taking place in the double chamber prefilled syringes market during the forecast period. Key inclusions of the study also consist of Porter’s Five Forces analysis, PEST analysis, footprint matrix of competitors, investment feasibility index, regulatory assessment, supply chain analysis, and product adoption trend. The report studies the concentration of the key market players by estimating their profiles that include their product portfolio, financials, and key strategies.

Double Chamber Prefilled Syringes Market – Segmentation

PMR’s report assesses the double chamber prefilled syringes market based on the product type, material type, application, indication, distribution channel, and region. With the help of the segmentation of the report, the readers can find key insights into the attractiveness of the double chamber prefilled syringes market.

By Product

By Material

By Application

By Indication

By Distribution Channel

By Region

  • <1.0 mL
  • 1.0 – 2.5 mL
  • 2.5 – 5.0 mL
  • >5 mL
  • Glass
  • Plastic
  • Liquid/

Liquid

  • Liquid/

Powder

  • Liquid/

Lyophilisate

  • Hemophilia
  • Schizophrenia
  • Diabetes
  • Erectile Dysfunction
  • Endometriosis
  • Precocious Puberty
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • North America

 

  • Latin America

 

  • Europe

 

  • South Asia

 

  • East Asia

 

  • Oceania

 

  • MEA

Double Chamber Prefilled Syringes Market – Key Questions Answered

Analyzing the double chamber prefilled syringes market from every aspect, PMR’s business asset brings to the fore actionable intelligence that readers can leverage to gain a competitive edge. The author of the study assesses the double chamber prefilled syringes market thoroughly and precisely estimates it during the forecast period. The report addresses numerous questions that will allow the readers to have a crystal clear view of the double chamber prefilled syringes market. Some of the questions answered in the double chamber prefilled syringes market study comprise of:

  • What are the notable developments in the double chamber prefilled syringes market?
  • What are the winning imperatives for the double chamber prefilled syringes market players?
  • How is the double chamber prefilled syringes market anticipated to develop over the course of the forecast period?
  • What are the significant trends influencing the expansion of the double chamber prefilled syringes market?
  • What are the crucial opportunities and challenges encountered by the stakeholders of the double chamber prefilled syringes market?
  • Which distribution channel is anticipated to bode impressive sales prospects to the double chamber prefilled syringes market?

Double Chamber Prefilled Syringes Market – Report Methodology

The research study followed by our analysts includes detailed research through primary and secondary resources. In order to carry out the primary research, interviews were conducted with key opinion leaders and industry heads of the double chamber prefilled syringes market. Average selling price was taken into consideration to estimate the value of the double chamber prefilled syringes market.

In order to conduct secondary research, company websites, company annual reports, and financial reports were taken into consideration. The paid publications which were studied include Morningstar and Factiva. Once distinguished insights into the double chamber prefilled syringes market is obtained, the data is validated with the help of the triangulation method.

Comapnies Profiles

  • Pfizer Inc.
  • Biosciences, Inc.
  • Ypsomed AG
  • Otsuka America Pharmaceutical, Inc.
  • Credence MedSystems, Inc.
  • Vetter Pharma International GmbH
  • MAEDA INDUSTRY Co., Ltd.
  • AstraZeneca plc
  • AbbVie Inc.
  • Nipro Corporation
  • SCHOTT AG

 

Back To Top